Local intrawound vancomycin powder decreases the risk of surgical site infections in complex adult deformity reconstruction: A cost analysis

Spine

Volumn 39, Issue 22, 2014, Pages 1875-1880

  Theologis, Alexander A ^a   Demirkiran, Gokhan ^b   Callahan, Matt ^a   Pekmezci, Murat ^a   Ames, Christopher ^c   Deviren, Vedat ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HACETTEPE UNIVERSITY   (Turkey)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

adult spinal deformity; cost effectiveness; surgical site infection; vancomycin powder

Indexed keywords

VANCOMYCIN; ANTIINFECTIVE AGENT; POWDER;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; FOLLOW UP; HOSPITAL READMISSION; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; OSTEOTOMY; PEROPERATIVE CARE; POWDER; PRIORITY JOURNAL; SPINE MALFORMATION; SPINE SURGERY; SURGICAL INFECTION; ADOLESCENT; ADVERSE EFFECTS; ANTIBIOTIC PROPHYLAXIS; COST BENEFIT ANALYSIS; COST CONTROL; ECONOMICS; HEALTH CARE COST; MIDDLE AGED; RETROSPECTIVE STUDY; SPINAL DISEASES; SPINE FUSION; STATISTICS AND NUMERICAL DATA; SURGICAL WOUND INFECTION; THERAPEUTIC USE; TOPICAL DRUG ADMINISTRATION; VERY ELDERLY; YOUNG ADULT;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; COST SAVINGS; COST-BENEFIT ANALYSIS; FEMALE; FOLLOW-UP STUDIES; HEALTH CARE COSTS; HUMANS; INTRAOPERATIVE CARE; MALE; MIDDLE AGED; PATIENT READMISSION; POWDERS; RETROSPECTIVE STUDIES; SPINAL DISEASES; SPINAL FUSION; SURGICAL WOUND INFECTION; VANCOMYCIN; YOUNG ADULT;

EID: 84929509372     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0000000000000533     Document Type: Article

References (28)

1. De Lissovoy G, Fraeman K, Hutchins V, et al. Surgical site infection: incidence and impact on hospital utilization and treatment costs. Am J Infect Control 2009; 37: 387-97
2. Herwaldt LA, Cullen JJ, Scholz D, et al. A prospective study of outcomes, healthcare resource utilization, and costs associated with postoperative nosocomial infections. Infect Control Hosp Epidemiol 2006; 27: 1291-8
3. O'Neill KR, Smith JG, Abtahi AM, et al. Reduced surgical site infections in patients undergoing posterior spinal stabilization of traumatic injuries using vancomycin powder. Spine J 2011; 11: 641-6
4. Kirkland KB, Briggs JP, Trivette SL, et al. The impact of surgicalsite infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol 1999; 20: 725-30
5. Chiang H-Y, Herwaldt LA, Blevins AE, et al. Effectiveness of local vancomycin powder to decrease surgical site infections: a metaanalysis. Spine J 2014; 14: 397-407
6. Pull ter Gunne AF, van Laarhoven CJ, Cohen DB. Surgical site infection after osteotomy of the adult spine: does type of osteotomy matter ? Spine J 2010; 10: 410-6
7. Pull ter Gunne AF, Cohen DB. Incidence, prevalence, and analysis of risk factors for surgical site infection following adult spinal surgery. Spine (Phila Pa 1976) 2009; 34: 1422-8
8. Reichman DE, Greenberg JA. Reducing surgical site infections: a review. Rev Obstet Gynecol 2009; 2: 212-21
9. Sweet FA, Roh M, Sliva C. Intrawound application of vancomycin for prophylaxis in instrumented thoracolumbar fusions. Spine (Phila Pa 1976) 2011; 36: 2084-8
10. Stall AC, Becker E, Ludwig SC, et al. Reduction of postoperative spinal implant infection using gentamicin microspheres. Spine (Phila Pa 1976) 2009; 34: 479-83
11. Cavanaugh DL, Berry J, Yarboro SR, et al. Better prophylaxis against surgical site infection with local as well as systemic antibiotics. An in vivo study. J Bone Joint Surg Am 2009; 91: 1907-12
12. Yarboro SR, Baum EJ, Dahners LE. Locally administered antibiotics for prophylaxis against surgical wound infection. An in vivo study. J Bone Joint Surg Am 2007; 89: 929-33
13. Molinari RW, Khera OA, Molinari WJ III. Prophylactic intraoperative powdered vancomycin and postoperative deep spinal wound infection: 1512 consecutive surgical cases over a 6-year period. Eur Spine J 2012; 21: 476-82
14. Pahys J, Pahys JR, Cho SK, et al. Methods to decrease postoperative infections following posterior cervical spine surgery. Spine J 2011; 11: S136
15. Martin JR, Adogwa O, Brown CR, et al. Experience with intrawound vancomycin powder for spinal deformity surgery. Spine (Phila Pa 1976) 2014; 39: 177-84
16. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-83
17. Glotzbecker MP, Riedel MD, Vitale MG, et al. What's the evidence? Systematic literature review of risk factors and preventive strategies for surgical site infection following pediatric spine surgery. J Pediatr Orthop 2013; 33: 479-87
18. Olsen MA, Mayfi eld J, Lauryssen C, et al. Risk factors for surgical site infection in spinal surgery. J Neurosurg 2003; 98: 149-55
19. Fang A, Hu SS, Endres N, et al. Risk factors for infection after spinal surgery. Spine (Phila Pa 1976) 2005; 30: 1460-5
20. Paulus MC, Kalantar SB, Radcliff K. Cost and value of spinal deformity surgery. Spine (Phila Pa 1976) 2014; 39: 388-93
21. Godil SS, Parker SL, O'Neill KR, et al. Comparative effectiveness and cost-benefi t analysis of local application of vancomycin powder in posterior spinal fusion for spine trauma. J Neurosurg Spine 2013; 19: 331-5
22. Caroom C, Tullar JM, Benton EG, et al. Intrawound vancomycin powder reduces surgical site infections in posterior cervical fusion. Spine (Phila Pa 1976) 2013; 38: 1183-7
23. Vitale MG, Riedel MD, Glotzbecker MP, et al. Building consensus: development of a Best Practice Guideline (BPG) for surgical site infection (SSI) prevention in high-risk pediatric spine surgery. J Pediatr Orthop 2013; 33: 471-8
24. Schimmel JJP, Horsting PP, de Kleuver M, et al. Risk factors for deep surgical site infections after spinal fusion. Eur Spine J 2010; 19: 1711-9
25. Duewelhenke N, Krut O, Eysel P. Infl uence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines. Antimicrob Agents Chemother 2007; 51: 54-63
26. Rathbone CR, Cross JD, Brown KV, et al. Effect of various concentrations of antibiotics on osteogenic cell viability and activity. J Orthop Res 2011; 29: 1070-4
27. Edin ML, Miclau T, Lester GE, et al. Effect of cefazolin and vancomycin on osteoblasts in vitro. Clin Orthop Relat Res 1996; 333: 245-51
28. Ghobrial GM, Thakkar V, Andrews E, et al. Intraoperative vancomycin use in spinal surgery: single institution experience and microbial trends. Spine (Phila Pa 1976) 2014; 39: 550-5.